| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | AZITHROMYCIN | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM | 3 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Bicaruvas Double Action Antacid | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use azithromycin tablets safely and effectively. See full prescribing information for azithromycin tablets . AZITHROMYCIN tablets USP for oral use Initial U.S. Approval: 1991 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CITALOPRAM HYDROBROMIDE | 3 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Bicaruvas Double Action Antacid | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | 15fd4cd0-3d68-33ea-e054-00144ff8d46c | 2 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | AZITHROMYCIN MONOHYDRATE | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use valsartan tablets USP safely and effectively. See full prescribing information for valsartan tablets USP. VALSARTAN tablets USP for oral use Initial U.S. Approval: 1996 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 1999 | 2 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 1997 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets USP safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets USP. PANTOPRAZOLE Sodium Delayed-Release Tablets USP for oral use Initial U.S. Approval: 2000 | 2 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | e6c92a3f-e194-4f28-bd8c-e1794cd6f448 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets. LEVETIRACETAM Tablets USP, for oral use Initial U.S. Approval: 1999 | 2 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets. Levetiracetam Tablets USP, for oral use Initial U.S. Approval: 1999 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use donepezil hydrochloride tablets USP safely and effectively. See full prescribing information for donepezil hydrochloride tablets USP. DONEPEZIL hydrochloride tablets USP for oral use Initial U.S. Approval: 1996 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DICLOFENAC POTASSIUM TABLETS USP, 50 mg 0948 Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Drug Facts | 7 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | FACTIVE ® (gemifloxacin mesylate) Tablets | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 1999 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Drug Facts | 3 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | 7d8c8762-e491-4798-8866-0db6425308e8 | 2 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 1997 | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | 4aad770b-a342-45c5-8199-21a124060314 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 1997 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Levetiracetam | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 2000 | 2 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Drug Facts | 2 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DICLOFENAC POTASSIUM TABLETS USP, 50 mg 0948 Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Granisetron hydrochloride tablets | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLETS USP, 600 mg Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DRUG FACTS | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Drug Facts | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | drug facts | 11 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 2000 | 2 | |
| Polyethylene glycol 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use ZYPREXA safely and effectively. See full prescribing information for ZYPREXA. ZYPREXA (olanzapine) Tablet for Oral use ZYPREXA ZYDIS (olanzapine) Tablet, Orally Disintegrating for Oral use ZYPREXA IntraMuscular (olanzapine) Injection, Powder, For Solution for Intramuscular use Initial U.S. Approval: 1996 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLETS USP, 600 mg Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DICLOFENAC POTASSIUM TABLETS USP, 50 mg 0948 Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLETS USP, 600 mg Rx only | 2 | |
| Polyethylene Glycol 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LIFElabs, a Division of Atico International USA, INC. | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLETS USP, 600 mg Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLETS USP, 600 mg Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | Levetiracetam Tablets | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DICLOFENAC POTASSIUM TABLETS USP, 50 mg 0948 Rx only | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | These highlights do not include all the information needed to use bicalutamide tablets USP safely and effectively. See full prescribing information for bicalutamide tablets USP. Bicalutamide Tablets USP for Oral use Initial U.S. Approval: 1995 | 1 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1001 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DONEPEZIL HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1000 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1000 | |
| Polyethylene glycol 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY
] | 45 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | SIMVASTATIN TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.] | 32 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | SEROQUEL XR (QUETIAPINE FUMARATE) TABLET, EXTENDED RELEASE SEROQUEL XR (QUETIAPINE FUMARATE) KIT [ASTRAZENECA PHARMACEUTICALS LP] | 30 | |
| polyethylene glycol 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | INVEGA SUSTENNA (PALIPERIDONE PALMITATE) INJECTION [JANSSEN PHARMACEUTICALS, INC.] | 19 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | BENAZEPRIL TABLET, COATED [INTERNATIONAL LABORATORIES, INC.] | 18 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | QUETIAPINE FUMARATE TABLET QUETIAPINE FUMARATE (QUETIAPINE FUMARATE ) TABLET [ASCEND LABORATORIES, LLC] | 18 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LOSARTAN POTASSIUM TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 17 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | SIMVASTATIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 17 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | TROSPIUM CHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 16 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 15 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] | 15 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | BENAZEPRIL HYDROCHLORIDE TABLET, COATED [TEVA PHARMACEUTICALS USA INC] | 14 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LOSARTAN POTASSIUM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 14 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 13 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CITALOPRAM HYDROBROMIDE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 13 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | QUETIAPINE FUMARATE TABLET, FILM COATED [SUN PHARMA GLOBAL FZE] | 12 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | FAMOTIDINE TABLET, FILM COATED [IVAX PHARMACEUTICALS, INC.] | 11 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 11 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 11 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 11 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | TOPIRAMATE TABLET [TEVA PHARMACEUTICALS USA INC] | 11 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | AZITHROMYCIN TABLET, FILM COATED [PLIVA, INC.] | 10 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 10 | |
| polyethylene glycol 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.] | 10 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | VALGANCICLOVIR (VALGANCICLOVIR HYDROCHLORIDE) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS] | 10 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CITALOPRAM HYDROBROMIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | EJECTDELAY GEL (BENZOCAINE 7.5%) GEL [INNOVUS PHARMACEUTICALS, INC.] | 9 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 9 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CLARITHROMYCIN TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CLOPIDOGREL TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.] | 8 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.] | 8 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM TABLET, FILM COATED [NORTHSTAR RX LLC] | 8 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | TRAMADOL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 8 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CEFUROXIME AXETIL TABLET [LUPIN PHARMACEUTICALS, INC.] | 7 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CITALOPRAM HYDROBROMIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 7 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | FAMOTIDINE TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC] | 7 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | QUETIAPINE FUMARATE TABLET [CARDINAL HEALTH] | 7 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | SILDENAFIL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 7 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | SIRINMEDI ONE (SODIUM MONOFLUOROPHOSPHATE) PASTE, DENTIFRICE [SUNGWON PHARMACEUTICAL CO., LTD.] | 7 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | APATITE (SODIUM MONOFLUOROPHOSPHATE) PASTE, DENTIFRICE [SUNGWON PHARMACEUTICAL CO., LTD.] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CLOPIDOGREL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DICLOFENAC POTASSIUM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | ETODOLAC TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | HYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [WATSON LABORATORIES, INC.] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LOSARTAN POTASSIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | NEWCHITO PLUS ONE (SODIUM MONOFLUOROPHOSPHATE) PASTE, DENTIFRICE [SUNGWON PHARMACEUTICAL CO., LTD.] | 6 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | BICALUTAMIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CLOPIDOGREL TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING] | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GEMFIBROZIL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | IODENT MAXIMUM STRENGTH ORAL ANALGESIC (BENZOCAINE) GEL [UNITED EXCHANGE CORP] | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM TABLET, FILM COATED [BLUEPOINT LABORATORIES] | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | MEMATINE HYDROCHLORIDE TABLET, FILM COATED [ORCHID CHEMICALS & PHARMACEUTICALS LIMITED] | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | PANTOPRAZOLE SODIUM TABLET [REMEDYREPACK INC. ] | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | VORICONAZOLE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 5 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | CLOPIDOGREL TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DERMAN ANTIFUNGAL (ZINC UNDECYLENATE) CREAM [COMPANIA INTERNACIONAL DE COMERCIO, S.A.P.I DE C.V.] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | DOCU (DOCUSATE SODIUM) LIQUID [HI-TECH PHARMACAL CO., INC.] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | GUAIATUSSIN AC (GUAIFENESIN AND CODEINE PHOSPHATE) LIQUID [HI-TECH PHARMACAL CO., INC.] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC.] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LETROZOLE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 4 | |
| POLYETHYLENE GLYCOL 4000 | INACTIVE INGREDIENT | 4R4HFI6D95 | RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 4 | |